Thiaplakortone B attenuates RANKL‐induced NF‐κB and MAPK signaling and dampens OVX‐induced bone loss in mice

Osteoclasts play an important role in maintaining the relative stability of bone mass. Abnormal number and function of osteoclasts are closely related to osteoporosis and osteolytic diseases. Thiaplakortone B (TPB), a natural compound derived from the Great Barrier Reef sponge Plakortis lita, has be...

Full description

Bibliographic Details
Main Authors: Qingqing Wang, Delong Chen, Yining Wang, Chenlin Dong, Jian Liu, Kai Chen, Fangming Song, Chao Wang, Jinbo Yuan, Rohan A. Davis, Vincent Kuek, Haiming Jin, Jiake Xu
Format: Article
Language:English
Published: Elsevier 2022-10-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332222010113
_version_ 1798003176380563456
author Qingqing Wang
Delong Chen
Yining Wang
Chenlin Dong
Jian Liu
Kai Chen
Fangming Song
Chao Wang
Jinbo Yuan
Rohan A. Davis
Vincent Kuek
Haiming Jin
Jiake Xu
author_facet Qingqing Wang
Delong Chen
Yining Wang
Chenlin Dong
Jian Liu
Kai Chen
Fangming Song
Chao Wang
Jinbo Yuan
Rohan A. Davis
Vincent Kuek
Haiming Jin
Jiake Xu
author_sort Qingqing Wang
collection DOAJ
description Osteoclasts play an important role in maintaining the relative stability of bone mass. Abnormal number and function of osteoclasts are closely related to osteoporosis and osteolytic diseases. Thiaplakortone B (TPB), a natural compound derived from the Great Barrier Reef sponge Plakortis lita, has been reported to inhibit the growth of the malaria parasite, Plasmodium falciparum, but its effect on osteoclastogenesis has not been previously investigated. In our study, we found that TPB suppresses the receptor activator of nuclear factor‐κB (NF-κB) ligand (RANKL)-induced osteoclast formation and resorption activity by tartrate‐resistant acid phosphatase (TRAcP) staining, immunofluorescence staining of F-actin belts and hydroxyapatite resorption assay. Furthermore, using quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting analysis, we discovered that TPB inhibits osteoclast-specific genes and proteins expression. Mechanistically, TPB blocks multiple upstream pathways including calcium oscillation, NF‐κB, mitogen-activated protein kinase (MAPK) and nuclear factor of activated T cells 1(NFATc1) signaling pathways. In vivo, TPB could dampen bone loss in an ovariectomy (OVX) mouse model by micro-CT assessment and histological staining. Therefore, TPB may serve as a potential therapeutic candidate for the treatment of osteoporosis and osteolysis.
first_indexed 2024-04-11T12:03:45Z
format Article
id doaj.art-227ad4820b88454781063235227d0673
institution Directory Open Access Journal
issn 0753-3322
language English
last_indexed 2024-04-11T12:03:45Z
publishDate 2022-10-01
publisher Elsevier
record_format Article
series Biomedicine & Pharmacotherapy
spelling doaj.art-227ad4820b88454781063235227d06732022-12-22T04:24:47ZengElsevierBiomedicine & Pharmacotherapy0753-33222022-10-01154113622Thiaplakortone B attenuates RANKL‐induced NF‐κB and MAPK signaling and dampens OVX‐induced bone loss in miceQingqing Wang0Delong Chen1Yining Wang2Chenlin Dong3Jian Liu4Kai Chen5Fangming Song6Chao Wang7Jinbo Yuan8Rohan A. Davis9Vincent Kuek10Haiming Jin11Jiake Xu12Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Medical College of Zhejiang University, Hangzhou, Zhejiang 310016, China; School of Biomedical Sciences, University of Western Australia, Perth, Western Australia 6009, AustraliaSchool of Biomedical Sciences, University of Western Australia, Perth, Western Australia 6009, AustraliaThe Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, ChinaThe Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, ChinaThe Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, ChinaSchool of Biomedical Sciences, University of Western Australia, Perth, Western Australia 6009, AustraliaResearch Centre for Regenerative Medicine and Guangxi Key Laboratory of Regenerative Medicine, Guangxi Medical University, Guangxi, 530021, ChinaSchool of Biomedical Sciences, University of Western Australia, Perth, Western Australia 6009, AustraliaSchool of Biomedical Sciences, University of Western Australia, Perth, Western Australia 6009, AustraliaGriffith Institute for Drug Discovery, School of Environment and Science, Griffith University, Queensland, 4111, AustraliaSchool of Biomedical Sciences, University of Western Australia, Perth, Western Australia 6009, Australia; Corresponding author.School of Biomedical Sciences, University of Western Australia, Perth, Western Australia 6009, Australia; The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; Corresponding author at: School of Biomedical Sciences, University of Western Australia, Perth, Western Australia 6009, Australia.Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Medical College of Zhejiang University, Hangzhou, Zhejiang 310016, China; School of Biomedical Sciences, University of Western Australia, Perth, Western Australia 6009, Australia; Corresponding author at: Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Medical College of Zhejiang University, Hangzhou, Zhejiang 310016, China.Osteoclasts play an important role in maintaining the relative stability of bone mass. Abnormal number and function of osteoclasts are closely related to osteoporosis and osteolytic diseases. Thiaplakortone B (TPB), a natural compound derived from the Great Barrier Reef sponge Plakortis lita, has been reported to inhibit the growth of the malaria parasite, Plasmodium falciparum, but its effect on osteoclastogenesis has not been previously investigated. In our study, we found that TPB suppresses the receptor activator of nuclear factor‐κB (NF-κB) ligand (RANKL)-induced osteoclast formation and resorption activity by tartrate‐resistant acid phosphatase (TRAcP) staining, immunofluorescence staining of F-actin belts and hydroxyapatite resorption assay. Furthermore, using quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting analysis, we discovered that TPB inhibits osteoclast-specific genes and proteins expression. Mechanistically, TPB blocks multiple upstream pathways including calcium oscillation, NF‐κB, mitogen-activated protein kinase (MAPK) and nuclear factor of activated T cells 1(NFATc1) signaling pathways. In vivo, TPB could dampen bone loss in an ovariectomy (OVX) mouse model by micro-CT assessment and histological staining. Therefore, TPB may serve as a potential therapeutic candidate for the treatment of osteoporosis and osteolysis.http://www.sciencedirect.com/science/article/pii/S0753332222010113Marine natural productThiaplakortone BOsteoclastogenesisNF‐κBMAPKOsteoporosis
spellingShingle Qingqing Wang
Delong Chen
Yining Wang
Chenlin Dong
Jian Liu
Kai Chen
Fangming Song
Chao Wang
Jinbo Yuan
Rohan A. Davis
Vincent Kuek
Haiming Jin
Jiake Xu
Thiaplakortone B attenuates RANKL‐induced NF‐κB and MAPK signaling and dampens OVX‐induced bone loss in mice
Biomedicine & Pharmacotherapy
Marine natural product
Thiaplakortone B
Osteoclastogenesis
NF‐κB
MAPK
Osteoporosis
title Thiaplakortone B attenuates RANKL‐induced NF‐κB and MAPK signaling and dampens OVX‐induced bone loss in mice
title_full Thiaplakortone B attenuates RANKL‐induced NF‐κB and MAPK signaling and dampens OVX‐induced bone loss in mice
title_fullStr Thiaplakortone B attenuates RANKL‐induced NF‐κB and MAPK signaling and dampens OVX‐induced bone loss in mice
title_full_unstemmed Thiaplakortone B attenuates RANKL‐induced NF‐κB and MAPK signaling and dampens OVX‐induced bone loss in mice
title_short Thiaplakortone B attenuates RANKL‐induced NF‐κB and MAPK signaling and dampens OVX‐induced bone loss in mice
title_sort thiaplakortone b attenuates rankl induced nf κb and mapk signaling and dampens ovx induced bone loss in mice
topic Marine natural product
Thiaplakortone B
Osteoclastogenesis
NF‐κB
MAPK
Osteoporosis
url http://www.sciencedirect.com/science/article/pii/S0753332222010113
work_keys_str_mv AT qingqingwang thiaplakortonebattenuatesranklinducednfkbandmapksignalinganddampensovxinducedbonelossinmice
AT delongchen thiaplakortonebattenuatesranklinducednfkbandmapksignalinganddampensovxinducedbonelossinmice
AT yiningwang thiaplakortonebattenuatesranklinducednfkbandmapksignalinganddampensovxinducedbonelossinmice
AT chenlindong thiaplakortonebattenuatesranklinducednfkbandmapksignalinganddampensovxinducedbonelossinmice
AT jianliu thiaplakortonebattenuatesranklinducednfkbandmapksignalinganddampensovxinducedbonelossinmice
AT kaichen thiaplakortonebattenuatesranklinducednfkbandmapksignalinganddampensovxinducedbonelossinmice
AT fangmingsong thiaplakortonebattenuatesranklinducednfkbandmapksignalinganddampensovxinducedbonelossinmice
AT chaowang thiaplakortonebattenuatesranklinducednfkbandmapksignalinganddampensovxinducedbonelossinmice
AT jinboyuan thiaplakortonebattenuatesranklinducednfkbandmapksignalinganddampensovxinducedbonelossinmice
AT rohanadavis thiaplakortonebattenuatesranklinducednfkbandmapksignalinganddampensovxinducedbonelossinmice
AT vincentkuek thiaplakortonebattenuatesranklinducednfkbandmapksignalinganddampensovxinducedbonelossinmice
AT haimingjin thiaplakortonebattenuatesranklinducednfkbandmapksignalinganddampensovxinducedbonelossinmice
AT jiakexu thiaplakortonebattenuatesranklinducednfkbandmapksignalinganddampensovxinducedbonelossinmice